How early is early in psoriatic arthritis? Is there a window of opportunity for treatment in PsA to ensure optimal outcomes? https://t.co/jHrA1M05Qr https://t.co/jcU13Y4CRm

Effective Treatments for Rheumatoid Arthritis ILD The ACR guidelines for the diagnosis and management of interstitial lung disease, which includes RA-ILD, has been one of the most controversial topics in the runup to ACR Convergence. https://t.co/qJBeM0jdom https://t.co/vdhcHOvHBI

Reduction of AxSpa-Associated Acute Anterior Uveitis with Certolizumab Acute anterior uveitis (AAU) is the most common extra-musculoskeletal manifestation in axial spondyloarthritis (axSpA), affecting up to 50% of patients in some age groups. https://t.co/uhlnpmLwoP https://t.co/NRW0PlD43a

Undiagnosed IBD in AxSpA Dr. Eric Dein (Summit, New Jersey) discusses Abstract #0495 presented at the ACR 2023 Convergence meeting in San Diego. https://t.co/QAC6fhSQ7Q https://t.co/BxNQwQ9nwc

The impact of SGLT2-inhibitor on SLE outcomes SLE is associated with increased risk of cardiovascular events due to both traditional and disease-specific risk factors. https://t.co/hyyMVQg3xV https://t.co/fLxh0vlTze

Are Rheumatologists doing Enough for Cervical Cancer? Should rheums be counseling patients on cervical cancer prevention and screening? The data from Abstract #1479 at #ACR23 suggests this should be an important conversation with our lupus patients. https://t.co/VFobM0T3u7 https://t.co/L45N3tsTdN

Substudy of the ADVOCATE trial looked at 214 ANCA assoc vasculitis pts treated with #RTX; avacopan Rx showed improved recovery of renal function, faster reduction in albuminuria and lower glucocorticoid toxicity compared to a prednisone taper. https://t.co/91PtvQfoIr https://t.co/ZjYCVP5lqG

Long term F/U of early RA, T2T RCTs (n 1616) finds excess mortality > 10yrs for BeST (SMR 1.32) & IMPROVED (SMR 1.33) RCTs; highest in ACPA+ smokers (SMR 2.80 & 2.14); Cancer main cause. SMR incr 34% & 13% for ea 1 pt incr in DAS https://t.co/2DdHMGIlOk https://t.co/7bnCOzB8vd

Infections During Treatment of GPA with Rituximab Dr. Richard Conway (Dublin, Ireland) discusses abstract 1584 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/eKi3KExEnk https://t.co/b9G9w5e9tc

Watch and Weigh In: Upadacitinib for Pain: Is That Real? Dr. David Liew reports on abstract 0429 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/AbD9UpXQfY https://t.co/iRgUnNInuD

Computer Vision: Is It Ready for RA Assessment? Dr. David Liew reports on abstract 0402 and 1293 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/4rQDjFXjH2 https://t.co/8FM40kh3bw

Hemophagocytic Lymphohistiocytosis in Still's Disease Dr. Bella Mehta discusses abstract 1143 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/bFeGK6MTcc https://t.co/cxJg6rQ7gm